Nikolaj heads up our Healthcare and Life Sciences practice and holds a Ph.D. from the University of Southern Denmark, where he is still a Research Fellow.
He advises pharmaceutical companies, patient organisations, industry associations, and public sector clients based on insights from data-driven and applied economic analyses. He provides clear stories on the societal and business impact of innovative treatments and regulatory changes.
Nikolaj specialises in health economics, real-world evidence (RWE), burden of illness studies, value of medicine studies, health economic outcomes research (HEOR), quality of life (QoL) measurement, and applied econometrics and has a particular interest in preventative treatments and plasma-derived therapies.
